Hematopoietic Innovative Therapies
“CIEMAT’s Hematopoietic Innovative Therapies group is focused on the development of translational research to improve the diagnosis and treatment of inherited and acquired pathologies through genetic, molecual and cellular biology techniques”
News
Back
Células mesenquimales, soluciones para mejorar su eficacia.
26/03/2021 Células mesenquimales, soluciones para mejorar su eficacia.
Un artículo de TerCel que aborda los nuevos enfoques para mejorar las propiedades y capacidades funcionales de las CMM tras distintas estrategias de bioingeniería celular.
Fanconi Anemia
A gene therapy clinical trial for patients with Fanconi Anemia offers its first successful results
Dyskeratosis Congenita
A new cell model of dyskeratosis congenita will help understand the disease and evaluate new therapies
LAD-I immunodeficiency
First successful results in gene therapy in a patient with LAD-I immunodeficiency
